ArticleTropical medicine and infectious disease2020
Emergence of Arboviruses in the United States: The Boom and Bust of Funding, Innovation, and Capacity.
Article in Tropical medicine and infectious disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Forgotten in the tropics: research on Culex mosquitoes is overshadowed in malaria and dengue-endemic regions.Parasites & vectors · 2026Pooled it
- Exploring the Mosquito-Arbovirus Network: A Survey of Vector Competence Experiments.The American journal of tropical medicine and hygiene · 2023Pooled it
- Advances in mosquito-borne disease surveillance using machine learning.New microbes and new infections · 2026Article
- Teaching inequity in vector-borne diseases management through a socioscientific issue framework.One health (Amsterdam, Netherlands) · 2025Article
- Arbovirus Epidemics as Global Health Imperative, Africa, 2023.Emerging infectious diseases · 2025Article
- A historical perspective on arboviruses of public health interest in Southern Africa.Pathogens and global health · 2024Review
- Ensemble species distribution modeling of Culex tarsalis (Diptera: Culicidae) in the continental United States.Journal of medical entomology · 2023Article
- The community-wide effectiveness of municipal larval control programs for West Nile virus risk reduction in Connecticut, USA.Pest management science · 2021Article
- Global Perspectives on Arbovirus Outbreaks: A 2020 Snapshot.Tropical medicine and infectious disease · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mosquito-borne viruses will continue to emerge and generate a significant public health burden around the globe. Here, we provide a longitudinal perspective on how the emergence of mosquito-borne viruses in the Americas has triggered reactionary funding by sponsored agencies, stimulating a number of publications, innovative development of traps, and augmented capacity. We discuss the return on investment (ROI) from the oscillation in federal funding that influences demand for surveillance and control traps and leads to innovation and research productivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.